clinical trial · NCT07263191
A Study of Olanzapine in Participants With Bipolar Disorder.
Boryung Pharmaceutical Co., Ltd·—·recruiting·n = 3,000
Bipolar DisorderOlanzapine
brief summary
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
started
Oct 30, 2025
primary completion
Sep 1, 2027
completion
Sep 1, 2027
last updated
Dec 4, 2025
official title
A Multicenter, Prospective Observational Study to Evaluate Treatment Patterns and Safety in Patients With Bipolar Disorder Taking Olanzapine
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol